PRESS RELEASES Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 218 Results March 18, 2015 Minerva Neurosciences Completes Private Placement, Raises $31 Million March 13, 2015 Minerva Neurosciences Announces $31 Million Financing January 21, 2015 Minerva Neurosciences Reports Positive Phase 1 Data With MIN-202, Selective Orexin-2 Antagonist for Treatment of Sleep Disorders Including Primary and Comorbid Insomnia January 20, 2015 Minerva Neurosciences Announces $15 Million Debt Facility With Oxford Finance LLC and Silicon Valley Bank January 5, 2015 Minerva Neurosciences Reports Positive Data Showing an Analog of Minerva’s MIN-301 Compound Improves Symptoms of Parkinson’s Disease in Primates December 3, 2014 Minerva Neurosciences Announces Completion of Development and Final Selection of Once-Daily Dose Formulation of MIN-101 for Its Schizophrenia Program November 25, 2014 Minerva Neurosciences Appoints Dr. Remy Luthringer as CEO November 13, 2014 Dr. Remy Luthringer, Minerva President and Chief Scientific Officer, to Present at CNS Summit November 6, 2014 Minerva Neurosciences Reports Third Quarter 2014 Financial Results October 30, 2014 Minerva Neurosciences to Host Third Quarter 2014 Financial Results Webcast and Conference Call «...1819202122